Edesa Biotech, Inc.

EDSA Nasdaq SEC CIK 1540159
Follow Edesa Biotech Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$5.4M −209.1% vs same quarter last year
EPS, diluted −$0.60 −140% vs same quarter last year
Operating cash flow −$3.1M −81.3% vs same quarter last year
Operating income −$5.5M −189.9% vs same quarter last year
Net income by quarter
−$962.1K
−$1.6M
−$1.6M
−$1.7M
−$2.2M
−$2.2M
−$4.2M
−$5.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$20M−$15M−$10M−$5M$0$5MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$7.2M
FY24-−$6.2M
FY23-−$8.4M
FY22-−$17.5M
FY21$0−$13.3M
FY20$328.8K−$6.4M
FY19$0−$1.5M
FY18$211.8K−$5M
FY17$228.3K−$5M
FY16$1.3M−$5M
FY15$758.7K−$2.8M
FY14$372.1K−$8.4M
FY13$545.5K−$14.5M
FY12$286.1K−$5.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−3000%−2000%−1000%0%1000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY24---
FY23---
FY22---
FY21---
FY2094.6%−1946.7%−1935.3%
FY19---
FY1837.1%−2397.1%−2378.6%
FY17−9.5%−2288.6%−2203.7%
FY1635.6%−386%−395.2%
FY1523.4%−571.9%−374.7%
FY14−26.1%−1536.7%−2267.9%
FY1389.5%-−2657.5%
FY12−49%-−1932.9%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23−$6.6M
FY22−$12.3M
FY21−$13.7M
FY20−$5M
FY19−$1.3M
FY18−$5M
FY17−$5M
FY16−$4.9M
FY15−$4.7M
FY14−$4.5M
FY13−$2.8M
FY12−$4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Edesa Biotech
  • Healthcare median
−3000%−2000%−1000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearEdesa BiotechHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22-−80.4%
FY21-−71.8%
FY20−1935.3%−62.2%
FY19-−46.2%
FY18−2378.6%−49.6%
FY17−2203.7%−45.9%
FY16−395.2%−36%
FY15−374.7%−37.8%
FY14−2267.9%−35.5%
FY13−2657.5%−37.1%
FY12−1932.9%−29.1%